Literature DB >> 525993

Assay of flucytosine (5-fluorocytosine) in human plasma by high-pressure liquid chromatography.

R W Bury, M L Mashford, H M Miles.   

Abstract

The use of the antifungal agent flucytosine has been associated with dose-related hepatotoxicity and bone marrow depression, and measurement of plasma concentrations is useful in determining dosage schedules. The present study describes a rapid, simple, and sensitive high-pressure liquid chromatographic analysis of plasma flucytosine which may be completed within 30 min of receipt of a plasma sample. Sample preparation is minimal and merely involves precipitation of plasma protein before injection onto a reverse-phase column. The method is accurate and reproducible and yields results comparable to or perhaps slightly superior to those obtained by conventional microbiological assay. The value of the procedure for routine use is enhanced by the freedom from interference by a large range of medications administered concurrently with flucytosine.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 525993      PMCID: PMC352900          DOI: 10.1128/AAC.16.5.529

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  11 in total

1.  Assay of flucytosine and furosemide by high-pressure liquid chromatography.

Authors:  A D Blair; A W Forrey; B T Meijsen; R E Cutler
Journal:  J Pharm Sci       Date:  1975-08       Impact factor: 3.534

2.  Fatal aplastic anemia resulting from flucytosine.

Authors:  R Meyer; J L Axelrod
Journal:  JAMA       Date:  1974-06-17       Impact factor: 56.272

3.  Rapid microbiological assay for 5-fluorocytosine.

Authors:  D J Schiavone; M D Page; J K Dawborn
Journal:  Br Med J       Date:  1973-11-17

4.  Treatment of disseminated candidiasis with 5-fluorocytosine.

Authors:  T Eilard; K Alestig; P Wahlén
Journal:  J Infect Dis       Date:  1974-08       Impact factor: 5.226

5.  5-fluorocytosine: an oral antifungal compound. A report on clinical and laboratory experience.

Authors:  P L Steer; M I Marks; P D Klite; T C Eickhoff
Journal:  Ann Intern Med       Date:  1972-01       Impact factor: 25.391

6.  Candida endocarditis treated with 5-fluorocytosine.

Authors:  C O Record; J M Skinner; P Sleight; D C Speller
Journal:  Br Med J       Date:  1971-01-30

7.  Rapid, simple bioassay for 5-fluorocytosine in the presence of amphotericin B.

Authors:  R L Kaspar; D J Drutz
Journal:  Antimicrob Agents Chemother       Date:  1975-04       Impact factor: 5.191

8.  Anti-Candida factors in serum and their inhibitors. I. Clinical and laboratory observations.

Authors:  D B Louria; J K Smith; R G Brayton; M Buse
Journal:  J Infect Dis       Date:  1972-02       Impact factor: 5.226

9.  Evidence for conversion of 5-fluorocytosine to 5-fluorouracil in humans: possible factor in 5-fluorocytosine clinical toxicity.

Authors:  R B Diasio; D E Lakings; J E Bennett
Journal:  Antimicrob Agents Chemother       Date:  1978-12       Impact factor: 5.191

10.  In vitro studies with 5-fluorocytosine.

Authors:  S Shadomy
Journal:  Appl Microbiol       Date:  1969-06
View more
  4 in total

1.  Improved procedure for determination of flucytosine in human blood plasma by high-pressure liquid chromatography.

Authors:  U Schwertschlag; L M Nakata; J Gal
Journal:  Antimicrob Agents Chemother       Date:  1984-09       Impact factor: 5.191

Review 2.  Clinical pharmacokinetics of systemic antifungal drugs.

Authors:  T K Daneshmend; D W Warnock
Journal:  Clin Pharmacokinet       Date:  1983 Jan-Feb       Impact factor: 6.447

Review 3.  Opportunistic invasive fungal infections: diagnosis & clinical management.

Authors:  Parisa Badiee; Zahra Hashemizadeh
Journal:  Indian J Med Res       Date:  2014-02       Impact factor: 2.375

4.  Liposomal flucytosine capped with gold nanoparticle formulations for improved ocular delivery.

Authors:  Heba F Salem; Sayed M Ahmed; Mahmoud M Omar
Journal:  Drug Des Devel Ther       Date:  2016-01-13       Impact factor: 4.162

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.